Yi Hao
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Extracellular vesicles in disease
- Glycosylation and Glycoproteins Research
- Circular RNAs in diseases
Papers in
-
- Glycosylation and Glycoproteins Research 9
- RNA modifications and cancer 9
- Ubiquitin and proteasome pathways 5
-
- Cancer-related molecular mechanisms research 6
- Co-authors
- Xia Guo (11 shared papers)Chun Xu (4 shared papers)Dali Wang (3 shared papers)Wei Yang (2 shared papers)Xin Li (7 shared papers)Qinbo Zhou (1 shared paper)Qinghua Lyu (1 shared paper)Zairong Wei (3 shared papers)
- Journals
- Frontiers in Oncology (4 papers)Journal of Clinical Oncology (3 papers)ACS Chemical Biology (2 papers)Advanced Science (2 papers)Cancer Gene Therapy (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yi Hao
71 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 233
- Molecular Biology 633
- Rehabilitation 39
- Immunology 122
- Radiology, Nuclear Medicine and Imaging 122
Countries citing papers authored by Yi Hao
This map shows the geographic impact of Yi Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Hao more than expected).
Fields of papers citing papers by Yi Hao
This network shows the impact of papers produced by Yi Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Hao. The network helps show where Yi Hao may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 78 | |
| 2 | 2020 | 70 | |
| 3 | 2020 | 63 | |
| 4 | 2015 | 60 | |
| 5 | 2021 | 53 | |
| 6 | 2014 | 50 | |
| 7 | 2013 | 43 | |
| 8 | 2015 | 41 | |
| 9 | 2015 | 41 | |
| 10 | 2014 | 39 | |
| 11 | 2021 | 38 | |
| 12 | 2020 | 38 | |
| 13 | 2009 | 33 | |
| 14 | 2022 | 31 | |
| 15 | 2021 | 31 | |
| 16 | 2020 | 29 | |
| 17 | 2010 | 28 | |
| 18 | 2019 | 27 | |
| 19 | 2021 | 27 | |
| 20 | 2016 | 25 |
About Yi Hao
Yi Hao is a scholar working on Molecular Biology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Immunology and Biomedical Engineering, having authored 75 papers that have together received 1.3k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (9 papers), RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (6 papers), Ultrasound Imaging and Elastography (6 papers), Ubiquitin and proteasome pathways (5 papers), Carbohydrate Chemistry and Synthesis (5 papers), Galectins and Cancer Biology (4 papers) and Ultrasound and Hyperthermia Applications (4 papers). The work is most often cited by research in Cancer Research (233 citations), Molecular Biology (633 citations), Rehabilitation (39 citations), Immunology (122 citations) and Radiology, Nuclear Medicine and Imaging (122 citations). Yi Hao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xia Guo, Chun Xu, Dali Wang, Wei Yang, Xin Li, Qinbo Zhou, Qinghua Lyu, Zairong Wei, Jun Zhao and Han Zhang. Their work appears in journals such as Frontiers in Oncology, Journal of Clinical Oncology, ACS Chemical Biology, Advanced Science and Cancer Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.